IP Library › Granted Patent US 8,710,246
Granted Patent B2
US 8,710,246 · App. 13/124,621 · Granted Apr 29, 2014

Substituted thiophene pentamers

Inventors: Peter Åsberg (Stockholm, SE); Leif Johansson (Linköping, SE); Anna Herland (Solna, SE); Andreas Åslund (Linköping, SE); Peter Konradsson (Skänninge, SE)
Assignee: Biochromix Newco AB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,710,246
App. No.
13/124,621
Granted
Apr 29, 2014
Kind
B2
Abstract

A compound is provided of the formula wherein each u is independently selected from 0 and 1; each R 2 and R 4 is independently selected from carboxy, carboxyalkyl, alkoxycarbonylalkyl, aminoalkyl, (amino)(carboxy)alkyl and (amino)(carboxy)alkoxy; or a pharmaceutically acceptable salt thereof.

Claims (16)

1. A compound of the formula

wherein

each u is independently selected from 0 and 1;

each R 2 and R 4 is independently selected from carboxy, carboxyalkyl, alkoxycarbonylalkyl, aminoalkyl, (amino)(carboxy)alkyl and (amino)(carboxy)alkoxy;

or a pharmaceutically acceptable salt thereof.

2. The compound according to claim 1 , wherein each R 2 is independently selected from carboxyalkyl, alkoxycarbonylalkyl, aminoalkyl, (amino)(carboxy)alkyl and (amino)(carboxy)alkoxy.

3. The compound according to claim 1 , wherein each R 4 is carboxy.

4. The compound according to claim 1 , wherein each u=1.

5. The compound according to claim 1 , wherein the compound is

or a pharmaceutically acceptable salt thereof.

6. The compound according to claim 1 , wherein the compound is

or a pharmaceutically acceptable salt thereof.

7. The compound according to claim 1 , wherein the compound is

or a pharmaceutically acceptable salt thereof.

8. The compound according to claim 1 , wherein the compound is

or a pharmaceutically acceptable salt thereof.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2017
From: CPL BCX PHARMA AB
To: NEUROSCIOS GMBH
Reel/Frame 043548/0172 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2014
From: PIX FÖRVALTNING AB
To: BIOCHROMIX NEWCO AB
Reel/Frame 032314/0725 →
CHANGE OF NAME Recorded Feb 27, 2014
From: BIOCHROMIX PHARMA AB
To: PIX FÖRVALTNING AB
Reel/Frame 032364/0785 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2012
From: BIOCHROMIX AB
To: BIOCHROMIX PHARMA AB
Reel/Frame 027514/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2012
From: ASBERG, PETER; JOHANSSON, LEIF; HERLAND, ANNA; ASLUND, ANDREAS; KONRADSSON, PETER
To: BIOCHROMIX AB
Reel/Frame 027519/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2012
From: ASBERG, PETER; HERLAND, ANNA; JOHANSSON, LEIF; KONRADSSON, PETER; ASLUND, ANDREAS
To: BIOCHROMIX AB
Reel/Frame 027519/0409 →
Priority Claims (2)
SE 0850043 · Oct 17, 2008 · national
SE 0850050 · Oct 23, 2008 · national
Continuity (1)
Related Publication 20120157516A1 · Jun 21, 2012